Clinical Trial Update: OCS-01 in Treating Inflammation and Pain in Post-cataract Patients [Phase 2]

View source ↗

Summary

Phase 2 trial of OCS-01 for corneal inflammation and postoperative pain completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Inflammation
• Postoperative Pain

Drugs mentioned

• OCS-01

Snippet

Sponsor: Oculis | Conditions: Inflammation Corneal, Pain, Postoperative | Phase 2 | Status: COMPLETED | Results posted: 2022-03-15